1. Home
  2. AMC vs DRTS Comparison

AMC vs DRTS Comparison

Compare AMC & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Entertainment Holdings Inc.

AMC

AMC Entertainment Holdings Inc.

HOLD

Current Price

$2.83

Market Cap

993.9M

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$11.73

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMC
DRTS
Founded
1920
2015
Country
United States
Israel
Employees
N/A
121
Industry
Movies/Entertainment
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
993.9M
1.0B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
AMC
DRTS
Price
$2.83
$11.73
Analyst Decision
Hold
Strong Buy
Analyst Count
4
3
Target Price
$2.03
$8.67
AVG Volume (30 Days)
49.9M
660.8K
Earning Date
05-05-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,848,900,000.00
N/A
Revenue This Year
$11.41
N/A
Revenue Next Year
$5.18
$699.98
P/E Ratio
N/A
N/A
Revenue Growth
4.57
N/A
52 Week Low
$0.93
$2.98
52 Week High
$3.26
$14.11

Technical Indicators

Market Signals
Indicator
AMC
DRTS
Relative Strength Index (RSI) 70.16 48.26
Support Level $1.66 $11.51
Resistance Level $2.96 $14.00
Average True Range (ATR) 0.23 0.89
MACD 0.07 -0.24
Stochastic Oscillator 83.71 27.89

Price Performance

Historical Comparison
AMC
DRTS

About AMC AMC Entertainment Holdings Inc.

AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: